ArticleIJID regions2025
Crimean-Congo hemorrhagic fever, a real health problem in Iraq?
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Trends in Crimean-Congo Hemorrhagic Fever in Iraq, 2023-2025: A Descriptive Ecological Study of National Surveillance Data and Public Health Response Activities.Health science reports · 2026Article
- Global distribution, pathogen spectrum, and invasion potential ofOne health (Amsterdam, Netherlands) · 2026Article
- Clinical Characteristics, Risk Factors, and Predictors of Fatal Outcomes and Prolonged Hospitalization of Crimean-Congo Hemorrhagic Fever Cases in Basrah, Iraq.Infectious disease reports · 2026Article
- Climate change and infectious diseases: breaking the poverty-disease-environment trap.Infectious diseases of poverty · 2026Article
- Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus.PLoS neglected tropical diseases · 2026Article
- Assessment of Butchers' Awareness, Attitude, and Occupational Practices Toward Crimean-Congo Hemorrhagic Fever (CCHF) in Kabul, Afghanistan: A Cross-Sectional Study.Health science reports · 2026Article
- Tick threats in the context of climate change: One Health response strategies in the Middle East and North Africa region.Science in One Health · 2026Review
- An Overview of the Crimean-Congo Hemorrhagic Fever Outbreak in Iraq.Open forum infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Crimean-Congo hemorrhagic fever (CCHF) is the most widespread tick-borne viral disease worldwide. CCHF was not recognized in Iraq before 1979, after which many outbreaks occurred, and the disease became endemic with the re-emergence of outbreaks. This study aimed to analyze the epidemiology of the largest outbreak in Iraqi history in 2023. Methods: This retrospective study included human CCHF cases from 2023. Results: 2186 suspected cases were investigated. There were 587 confirmed cases, and 83 deaths, and an overall case fatality rate (14%). Among the confirmed cases, only 539 cases had complete data, and the analysis was performed on these cases. The majority 70.9% of patients lived in the southern provinces. Approximately 58% of the patients were male and up to half of the patients resided in rural areas. Approximately 45% of cases were in the 25-44 years age group. The occupations of the patients were as follows: 30% were housewives, 22% were butchers, 18% were animal owners, 30% had other occupations, and up to 60% had a history of exposure to fresh raw meat. Conclusions: The 2023 outbreak was the largest in Iraq in decades. The absence of preventive and control activities during the COVID-19 pandemic played an important role in the rise of cases and the presence of unlicensed and freelance slaughterers, especially during religious events played an important role in this epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.